You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2026

CLINICAL TRIALS PROFILE FOR SORBITOL 3% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sorbitol 3% In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000159 ↗ Sorbinil Retinopathy Trial (SRT) Completed National Eye Institute (NEI) Phase 3 1983-08-01 To evaluate the safety and efficacy of the investigational drug sorbinil, an aldose reductase inhibitor, in preventing the development of diabetic retinopathy and neuropathy in persons with insulin-dependent diabetes.
NCT00121433 ↗ Leptin and Endothelial Function Completed Amgen Phase 4 2004-09-01 The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.
NCT00121433 ↗ Leptin and Endothelial Function Completed University of Michigan Phase 4 2004-09-01 The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sorbitol 3% In Plastic Container

Condition Name

Condition Name for Sorbitol 3% In Plastic Container
Intervention Trials
Severe Mental Illness 2
Constipation 2
Intoxication 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sorbitol 3% In Plastic Container
Intervention Trials
Tooth Diseases 3
Nerve Compression Syndromes 3
Hereditary Sensory and Motor Neuropathy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sorbitol 3% In Plastic Container

Trials by Country

Trials by Country for Sorbitol 3% In Plastic Container
Location Trials
United States 29
China 7
Ukraine 4
Turkey 4
Canada 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sorbitol 3% In Plastic Container
Location Trials
New York 3
Kansas 3
California 3
Washington 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sorbitol 3% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Sorbitol 3% In Plastic Container
Clinical Trial Phase Trials
PHASE3 2
PHASE2 2
Phase 4 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sorbitol 3% In Plastic Container
Clinical Trial Phase Trials
Completed 17
Recruiting 10
Unknown status 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sorbitol 3% In Plastic Container

Sponsor Name

Sponsor Name for Sorbitol 3% In Plastic Container
Sponsor Trials
Yuria-Pharm 4
Sahlgrenska University Hospital, Sweden 3
ScandiBio Therapeutics AB 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sorbitol 3% In Plastic Container
Sponsor Trials
Other 52
Industry 21
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sorbitol 3% In Plastic Container Market Analysis and Financial Projection

Last updated: February 7, 2026

What is the current status of clinical trials for Sorbitol 3% in Plastic Containers?

As of the latest available data, there are no publicly listed ongoing or upcoming clinical trials specifically for Sorbitol 3% packaged in plastic containers. The majority of clinical research on sorbitol pertains to its systemic effects, laxative use, and application as a sweetener, rather than its specific formulation in plastic packaging.

The absence of dedicated clinical trials for this exact formulation indicates that safety or efficacy studies explicitly focusing on Sorbitol 3% in plastics have not been publicly disclosed or registered with major clinical trial registries such as ClinicalTrials.gov or the WHO International Clinical Trials Registry Platform.

How is Sorbitol 3% in Plastic Containers Marketed?

Sorbitol 3% in plastic containers mainly serves as a consumable product in the following sectors:

  • Oral care products, such as mouthwashes and dental gels
  • Topical applications in pharmaceuticals and skincare
  • Food industry as a sweetener (though typically in liquids or syrups, not necessarily at 3% concentration)

Manufacturers package Sorbitol 3% in plastic containers primarily for convenience, stability, and ease of dosing. These products are marketed to both consumer and institutional markets based on existing safety profiles and regulatory approval for use as a sweetener and humectant.

What is the Market Size and Growth Projection?

The global sorbitol market was valued at approximately $1.2 billion in 2021 and is projected to reach around $2.2 billion by 2028, growing at a compound annual growth rate (CAGR) of 8.5%.[1] The consumer segment accounts for roughly 60% of this value, with the oral care and food sectors being primary drivers.

The distribution of sorbitol formulations, including the 3% concentration in plastics, is influenced interest in:

  • Non-caloric sweeteners in food and beverage segments
  • Cosmetic and pharmaceutical topical applications
  • Medical oral rinse solutions

The specific niche of Sorbitol 3% in plastic containers is expected to grow proportionally with these broader trends, especially as demand for low-calorie, safe sweeteners increases globally.

How Does Packaging Impact the Market for Sorbitol 3%?

Packaging, especially the use of plastics, influences the market in terms of:

  • Cost efficiency: Plastic containers reduce manufacturing costs.
  • Stability: Plastic is chemically compatible with sorbitol, minimizing degradation.
  • Consumer convenience: Plastic bottles simplify handling and dosing.

The safety profile of plastics, particularly polyethylenes or polypropylenes, aligns with regulatory standards for food and pharmaceutical packaging, supporting widespread adoption.

Regulatory Environment and Safety Profile

Sorbitol is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA) and similar agencies globally. Packaging materials are compliant with organizations such as the FDA's guidelines for Food Contact Materials and the EU’s Regulation (EC) No 1935/2004.

There are no specific restrictions or additional approvals needed for sorbitol in plastics when used under standard conditions. However, manufacturers must adhere to regulations concerning plastic additive migration limits, especially in products intended for oral or dermal use.

Key Competitors and Market Players

Major companies involved in sorbitol manufacturing, packaging, and distribution include:

  • Cargill Incorporated
  • Roquette Frères
  • Archer Daniels Midland Company (ADM)
  • Gulshan Polyols Ltd.
  • Tereos Syral

These companies manufacture sorbitol in various purities and formulations, often offering packaging solutions including plastics tailored for specific applications.

Future Market Trends and Opportunities

Potential growth areas include:

  • Development of biodegradable plastic containers for sustainability
  • Increasing penetration into emerging markets with expanding personal care and food sectors
  • Innovation in sachets and single-use packaging to enhance convenience

Investment in R&D to optimize shelf stability, reduce migration, and improve packaging sustainability could create new market opportunities.

Key Takeaways

  • No dedicated clinical trials for Sorbitol 3% in plastic containers are publicly registered.
  • The broader sorbitol market is expanding, projected to reach $2.2 billion by 2028 with an 8.5% CAGR.
  • Packaging in plastics offers cost, stability, and consumer advantages, supporting market growth.
  • Regulatory frameworks favor sorbitol’s safety, with packaging compliance being straightforward under existing standards.
  • Key competitors focus on manufacturing, with packaging solutions tailored to industry needs.

FAQs

1. Are there safety concerns related to sorbitol in plastic containers?
Sorbitol is safe when used within regulatory limits. Proper packaging ensures chemical stability, and plastics used comply with safety standards for food and pharmaceutical contact.

2. What applications drive demand for Sorbitol in plastic containers?
Demand stems from oral care products, topical formulations, food sweeteners, and consumer products requiring easy-to-handle packaging.

3. Is there potential for clinical research specific to Sorbitol 3% formulations?
Currently, no. Most research focuses on sorbitol's systemic effects or its use as an ingredient, not on specific packaging formats.

4. How does packaging influence sorbitol product distribution?
Plastics enable cost-effective, stable, and user-friendly containers, facilitating wider distribution and consumer compliance.

5. What regulatory changes could impact this market?
Shifts toward sustainability and stricter migration limits in packaging materials could influence packaging choices and formulation strategies.


Citations

[1] Research and Markets, "Global Sorbitol Market by Formulation, Application, and Region," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.